Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma

Incidence of pancreatic ductal adenocarcinoma (PDAC) is increasing. Most patients have advanced disease at diagnosis and therapeutic options in this setting are limited. Gemcitabine plus nab-paclitaxel regimen was demonstrated to increase survival compared with gemcitabine monotherapy and is therefo...

Descripción completa

Detalles Bibliográficos
Autores principales: Neuzillet, Cindy, Babai, Samy, Kempf, Emmanuelle, Pujol, Géraldine, Rousseau, Benoît, Le-Louët, Hervé, Christophe Tournigand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937927/
https://www.ncbi.nlm.nih.gov/pubmed/27368013
http://dx.doi.org/10.1097/MD.0000000000004006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937927/
https://www.ncbi.nlm.nih.gov/pubmed/27368013
http://dx.doi.org/10.1097/MD.0000000000004006

Ejemplares similares